Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Mar 01, 2024
Episode
208
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of first-line amivantamab plus chemotherapy for NSCLC with an EGFR exon 20 insertion based on the phase III PAPILLON trial. These data were first shared at ESMO 2023 in Madrid with a simultaneous publication in the New England Journal of Medicine.
Guest
Michael Boyer
MD
Professor
University of Sydney
Angel Qin
MD
Clinical Assistant Professor and Co-Chair of the Thoracic Clinical Research Team
University of Michigan Rogel Cancer Center
